Ir para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Median time to pain improvemen...
  • Citar
  • Enviar por SMS
  • Enviar por email
  • Imprimir
  • Exportar registo
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Permanent link
Exportação concluída — 
Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib

Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib

Detalhes bibliográficos
Main Authors: de Vlam, K, Ogdie, A, Bushmakin, A, Cappelleri, J, Fleischmann, R, Taylor, P, Azevedo, V, Fallon, L, Maniccia, A, Woolcott, J, Mease, P
Formato: Conference item
Publicado em: Wiley 2018
  • Exemplares
  • Descrição
  • Registos relacionados
  • Registo fonte

Registos relacionados

  • Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
    Por: de Vlam, K, et al.
    Publicado em: (2021)
  • Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
    Por: Ogdie, A, et al.
    Publicado em: (2018)
  • Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
    Por: Taylor, P, et al.
    Publicado em: (2019)
  • Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
    Por: de Vlam, K, et al.
    Publicado em: (2022)
  • Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
    Por: Taylor, PC, et al.
    Publicado em: (2020)

Opções de Pesquisa

  • Histórico de Pesquisas
  • Pesquisa Avançada

Encontrar Mais

  • Percorrer o Catálogo
  • Percorrer por ordem alfabética
  • Explore Channels
  • Bibliografia Recomendada
  • Novos exemplares

Precisa de ajuda?

  • Dicas de Pesquisa
  • Serviço de Referência
  • FAQs